Open access · CC-BY
via OpenAlex
Drug‐Based Lifespan Extension in Mice Strongly Affects Lipids Across Six Organs
Sara Greenfield, Nathaniel C. Stevens, Lauren Bishop, Zachary Rabow, Daniela C. Soto, Abdali Omar Abdullah, Richard A. Miller, Oliver Fiehn
Aging Cell · 2025 · ▲ 4 citations
Abstract
Caloric restriction(definition) is associated with slow aging in model organisms. Additionally, some drugs have also been shown to slow aging in rodents. To better understand metabolic mechanisms that are involved in increased lifespan, we analyzed metabolomic differences in six organs of 12-month-old mice using five interventions leading to extended longevity, specifically caloric restriction, 17-α estradiol, and caloric restriction mimetics mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition), canagliflozin, and acarbose. These interventions generally have a stronger effect in males than in females. Using Jonckheere's trend test to associate increased average lifespans with metabolic changes for each sex, we found sexual dimorphism in metabolism of plasma, liver, gastrocnemius muscle, kidney, and inguinal fat. Plasma showed the strongest trend of differentially expressed compounds, highlighting potential benefits of plasma in tracking healthy aging. Using chemical set enrichment analysis, we found that the majority of these affected compounds were lipids, particularly in male tissues, in addition to significant differences in trends for amino acids, which were particularly apparent in the kidney. We also found strong metabolomic effects in adipose tissues. Inguinal fat exhibited surprising increases in neutral lipids with polyunsaturated side chains in male mice. In female mice, gonadal fat showed trends proportional to lifespan extension effect across multiple lipid classes, particularly phospholipids. Interestingly, for most tissues, we found similar changes induced by lifespan-extending interventions to metabolomic differences between untreated 12-month-old mice and 4-month-old mice. This finding implies that lifespan-extending treatments tend to reverse metabolic phenotypes to a biologically younger stage.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/acel.14465
- Canonical
- link ↗
- Fetched
- 2026-06-29 MST
Cite this
APA
Greenfield, S., Stevens, N.C., Bishop, L., Rabow, Z., Soto, D.C., Abdullah, A.O., Miller, R.A., & Fiehn, O. (2025). Drug‐Based Lifespan Extension in Mice Strongly Affects Lipids Across Six Organs. <em>Aging Cell</em>. https://doi.org/10.1111/acel.14465
Vancouver
Greenfield S, Stevens NC, Bishop L, Rabow Z, Soto DC, Abdullah AO, et al. Drug‐Based Lifespan Extension in Mice Strongly Affects Lipids Across Six Organs. Aging Cell. 2025. doi:10.1111/acel.14465.
BibTeX
@article{sara2025DrugBa,
title = {Drug‐Based Lifespan Extension in Mice Strongly Affects Lipids Across Six Organs},
author = {Sara Greenfield and Nathaniel C. Stevens and Lauren Bishop and Zachary Rabow and Daniela C. Soto and Abdali Omar Abdullah and Richard A. Miller and Oliver Fiehn},
journal = {Aging Cell},
year = {2025},
doi = {10.1111/acel.14465},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging cell 2025
Open access · OA
Drug-Based Lifespan Extension in Mice Strongly Affects Lipids Across Six Organs.
Journal of Clinical Investigation 2022
Open access · CC-BY
Metabolic changes in aging humans: current evidence and therapeutic strategies
Current Biology 2013
Open access · OA
Mutation, Condition, and the Maintenance of Extended Lifespan in Drosophila
Genome biology 2017
Open access · CC-BY
Epigenetic aging signatures in mice livers are slowed by dwarfism, calorie restriction and rapamycin treatment
Signal Transduction and Targeted Therapy 2022
Open access · CC-BY
Epigenetic regulation of aging: implications for interventions of aging and diseases
GeroScience 2022
Open access · OA